Proactively addressing affordability helps brand teams overcome access challenges during launch, and often increases patient engagement in and utilization of copay and other support programs over the life of the brand. Experienced pharma brand leaders know that affordability must be integrated into their brand strategy from the start.
GoodRx’s latest Yellow Paper provides fresh insights into the affordability gap for branded drugs across a range of specialties, shows how out-of-pocket (OOP) costs impact patient behavior, and offers three strategies you can use to improve communication about affordability options to patients and providers.
“Most pharma brand leaders today understand that patient affordability and pharmacy pull-through are essential components for their brand’s success.”
Download the Yellow Paper now to learn how:
• OOP costs correlate with patient fill rates • Affordability directly impacts pharmacy pull-through • Medical specialties have varying gaps between generic and brand OOPs • To design awareness into your patient support strategy • To identify and assess strategic external partners.
Learn more about GoodRx solutions that extend the reach of manufacturers’ copay programs and reduce medication affordability barriers for eligible patients.
Want to reach 160,000+ Fierce Pharma subscribers with your own message? Contact aalcover@questex.com or call 202-824-5074.
You are currently subscribed as newsletter@newslettercollector.com. If you no longer wish to receive communications from Fierce Pharma's trusted partners, simply click here to unsubscribe. Refer to our Privacy Policy.
Questex, LLC 685 3rd Avenue, 21st Floor New York, NY 10017
